Doctor profile · Federal record

Dr. Tasha Kouvatsos, M.D.

Endocrinology, Diabetes & Metabolism Physician (CMS: Endocrinology) · Student in an Organized Health Care Education/Training Program · Philadelphia, PA

  • NPI 1487888103
  • Accepts Medicare
  • 17 yrs in practice
  • Female
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
211 S 9Th St, Suite 600
Philadelphia, PA 191076810
(215) 955-1925
fax (215) 928-3160

Credentials & registration

NPPES · NUCC
NPI registered
May 2009 — 17 yrs on file
Profile last updated
September 11, 2015
Year of graduation
2009 — 17 yrs since
Specialty taxonomy
207RE0101X — NUCC code
State license (1)
Pennsylvania #MD446082
Medicaid
NJ #0472743

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1487888103. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
2,644
Distinct HCPCS
9
Medicare allowed
$151,225
HCPCS Description Services Patients Avg allowed
J0897 Injection, denosumab, 1 mg 1,500 13 $23
99214 Established patient office or other outpatient visit, 30-39 minutes 676 419 $133
82962 Blood glucose (sugar) test performed by hand-held instrument 241 133 $3
95251 Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report 61 36 $35
99215 Established patient office or other outpatient visit, 40-54 minutes 54 42 $186
99205 New patient office or other outpatient visit, 60-74 minutes 35 35 $229
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes 32 17 $82
96372 Injection of drug or substance under skin or into muscle 24 13 $15
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes 21 15 $123

In context: peer comparison

Among 28 peers in this city , average services per provider: 78. This provider delivers 34× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$154
Transactions
7
Manufacturers
3
Payer (manufacturer) Industry Txns Amount
Abbott Laboratories 4 $95.60
Lilly USA, LLC 2 $43.25
Novo Nordisk Inc 1 $14.98

By nature of payment

Food and Beverage
$154

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
2,549
Patients
729
Total drug cost
$1,194,950
Drug Type Claims Patients Total cost
Synthroid (Levothyroxine Sodium) Brand 494 125 $53,932
Levothyroxine Sodium Generic 459 124 $7,578
Metformin Hcl Er (Metformin Hcl) Brand 218 64 $4,641
Metformin Hcl Generic 213 66 $2,877
Ozempic (Semaglutide) Brand 191 55 $372,675
Jardiance (Empagliflozin) Brand 170 49 $272,607
Trulicity (Dulaglutide) Brand 124 35 $206,910
Glimepiride Generic 121 34 $1,888
Mounjaro (Tirzepatide) Brand 85 28 $139,125
Rosuvastatin Calcium Generic 85 23 $1,553

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Tasha Kouvatsos's medical specialty?
Dr. Tasha Kouvatsos practices Endocrinology, Diabetes & Metabolism Physician in Philadelphia, PA.
Where does Dr. Tasha Kouvatsos practice?
Dr. Tasha Kouvatsos practices at 211 S 9Th St, Philadelphia, PA 191076810. Office phone: 2159551925.
What is Dr. Tasha Kouvatsos's NPI?
Dr. Tasha Kouvatsos's National Provider Identifier (NPI) is 1487888103, issued by NPPES.
Does Dr. Tasha Kouvatsos accept Medicare assignment?
Yes. Dr. Tasha Kouvatsos accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Tasha Kouvatsos commonly perform?
Top Medicare-reported procedures in 2023: Injection, denosumab, 1 mg (HCPCS J0897); Established patient office or other outpatient visit (HCPCS 99214); Blood glucose (sugar) test performed by hand-held instrument (HCPCS 82962). Source: CMS Medicare Physician & Other Practitioners file.